financetom
Business
financetom
/
Business
/
Why Lucid Group Stock Is Bouncing Off All-Time Lows Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Lucid Group Stock Is Bouncing Off All-Time Lows Today
Nov 21, 2025 1:39 PM

Lucid Group Inc ( LCID ) is trading higher Friday afternoon, rebounding after the stock hit a fresh 52-week low of $11.46 earlier in the session. Here’s what investors need to know.

LCID stock is racing ahead of the pack. Check the market position here.

What To Know: Shares recently changed hands near $12.30 late Friday, more than 7% above the morning bottom, though still down roughly 38% over the past month and far below the 52-week high of $36.40.

The bounce comes as Treasury yields retreat after Federal Reserve officials signaled a more dovish tilt, with futures now heavily pricing a potential 25-basis-point rate cut at the December policy meeting.

Lower-rate expectations are particularly supportive for Lucid, a cash-burning luxury EV start-up whose valuation depends on discounted profits many years in the future.

A softer Fed path reduces financing costs on Lucid's recently issued $875 million convertible note due 2031 and improves the backdrop for any future capital raises needed to fund its Arizona manufacturing complex and ongoing expansion of the high-end Lucid Air sedan lineup.

After weeks of selling driven by disappointing third-quarter results, missed revenue, limited delivery growth and executive turnover, today's macro shift is fueling bargain hunting and short covering in beaten-down growth names.

Benzinga Edge Rankings: According to Benzinga Edge stock rankings, which provide four key scores to help investors spot leaders and laggards, Lucid currently carries a Momentum score of 6.37.

Read Also: VIX Surges 50% In November: History Shows Patient Investor Win Big After Panic

How To Buy LCID Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Lucid Group’s case, it is in the Consumer Discretionary sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Schneider National Keeps Quarterly Dividend at $0.095 a Share, Payable Oct. 8 to Shareholders of Record Sept. 13
--Schneider National Keeps Quarterly Dividend at $0.095 a Share, Payable Oct. 8 to Shareholders of Record Sept. 13
Jul 31, 2024
11:22 AM EDT, 07/31/2024 (MT Newswires) -- Price: 27.07, Change: +0.27, Percent Change: +0.99 ...
What's Going On With Meta Platforms Stock Wednesday?
What's Going On With Meta Platforms Stock Wednesday?
Jul 31, 2024
Meta Platforms Inc ( META ) shares are in the spotlight Wednesday ahead of earnings after the bell. Here’s what you need to know before the report. What To Know: Meta is due to report financial results for the second quarter after the market close on Wednesday. The company is expected to report earnings of $4.73 per share and revenue...
British Pharma Giant GSK's Blockbuster Shingles And Respiratory Syncytial Virus Vaccine Q2 Sales Miss Expectations, Cuts Annual Vaccine Revenue Guidance
British Pharma Giant GSK's Blockbuster Shingles And Respiratory Syncytial Virus Vaccine Q2 Sales Miss Expectations, Cuts Annual Vaccine Revenue Guidance
Jul 31, 2024
Wednesday, GSK Plc ( GSK ) reported second-quarter sales of $9.95 billion (7.88 billion Sterling Pounds), up 10% year-over-year and 13% on constant currency. The analysts estimated sales of $9.66 billion. Vaccines’ sales decreased 1% at constant currency to 1.99 billion pounds, reflecting increased demand for Meningitis vaccines and uptake of Arexvy in the U.S. in line with expected waning seasonal demand.  ...
StoneCo Reports Results of Tender Offer for Notes
StoneCo Reports Results of Tender Offer for Notes
Jul 31, 2024
11:24 AM EDT, 07/31/2024 (MT Newswires) -- StoneCo ( STNE ) on Wednesday reported the results of its tender offer to purchase its 3.95% senior notes due 2028. The company said the aggregate principal amount tendered in the offer, which expired Tuesday, was about $294.6 million or almost 59% of the outstanding principal amount of the notes. The final settlement...
Copyright 2023-2026 - www.financetom.com All Rights Reserved